Breaking News, World News and Taiwan News.
More Health Topics
  Aging    AIDS    Allergies    Arthritis/Pains    
  Cancer    Children’s Health    Cold & Flu    
  Diabetes    Eye Health    Genetics    Heart    
  Hypertension    Infectious Diseases    
  Mental Health    
  Nutrition & Fitness     Oral Hygiene     
  Sexual Health     Skin & Beauty     
  Pregnancy & Menopause    Stroke    
  Surgical News    Other    
A lawyer for the Irish manufacturer of an Alzheimer's drug urged a U.S. appeals court on Monday to let it replace a two-pill daily regimen with a single-dose version of the drug even if it cheats generic drugmakers of profits.
The United States Food and Drug Administration is warning consumers to avoid dietary supplements sold by a Las Vegas company because they may contain anabolic steroids that can cause liver damage.
Australian Prime Minister Tony Abbott said Sunday his nation will adopt a "no jab, no pay" policy to block parents who refuse to vaccinate their children from accessing some government welfare.
Once banned because it is a close cousin to marijuana, hemp is coming back in the state of Colorado and now has its own convention, attracting international interest as a new crop for farmers struggling to find new crops to stay afloat.
The U.S. and Liberian governments have just begun the first formal patient testing of an experimental Ebola virus treatment that's only been used on an emergency basis.
A new vaccine against sexually transmitted human papillomavirus is more effective than the previous version and may protect against 90 percent of all cervical cancers worldwide, researchers said Wednesday.
Floral nectar contains a bouquet of natural chemicals that may help fight parasite infection in bumble bees, a study said Wednesday.
U.S. President Barack Obama on Tuesday called for the United States to lead the way toward a "new era of medicine" by boosting funds for modern medical research.
The first in a new class of cancer medicines, Pfizer's Ibrance, appears poised for approval to treat advanced breast cancer within a few months and could quickly become a blockbuster, some analysts believe.
An Indian court has rejected German drug giant Bayer's bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.
Sitemap | Top Stories | Taiwan | China | Business | Asia | World | Sports | Life | Arts & Leisure | Health | Editorial | Commentary | Travel | Movies | TV Listings
Classifieds | Bookstore | Getting Around | Weather | Guide Post | Student Post | Subscribe | Advertise | About Us | Career | Contact Us
Copyright © 1999 – 2015 The China Post. Breaking news from Taiwan, China and the world.
The China Post  Terms of use